Peritoneal Surface Malignancy (CRS & HIPEC)
Overview

What is CRS & HIPEC?
Cytoreductive Surgery (CRS): Aims to remove all visible tumors from the peritoneal cavity.
HIPEC: After tumor removal, the abdominal cavity is treated with heated chemotherapy, killing any remaining microscopic cancer cells.
This combination has shown better disease control and improved survival rates compared to standard treatments.
Who Can Benefit?
CRS & HIPEC is mainly used for:
Appendiceal and colorectal cancers with peritoneal spread
Ovarian cancers
Peritoneal mesothelioma
Selected cases of gastric and rare abdominal cancers
Benefits of CRS & HIPEC
Improved survival in advanced-stage cancers
Targeted chemotherapy with fewer systemic side effects
Enhanced quality of life and longer disease-free intervals
Why Choose Dr. Akash Gopal Mor?
Specialized in advanced peritoneal surface malignancy management
Expertise in cytoreductive and HIPEC procedures
Training from Tata Memorial Hospital, Mumbai with experience in complex cancer surgeries
Patient-focused care emphasizing safety, precision, and recovery